U.K. Analyst Ratings and Price Targets (3/23/2021)
 

CompanyActionBrokerageCurrent PricePrice TargetRatingActions
AstraZeneca logo
AZN
AstraZeneca
 Target Set byThe Goldman Sachs GroupGBX 7,248
-1.3%		 GBX 6,800Sell    
AstraZeneca logo
AZN
AstraZeneca
 Target Set byUBS GroupGBX 7,248
-1.3%		 GBX 8,000Buy    
Unilever logo
ULVR
Unilever
 Target Set byDeutsche Bank AktiengesellschaftGBX 4,051
+0.7%		 GBX 5,500Buy    
Unilever logo
ULVR
Unilever
 Target Set byUBS GroupGBX 4,051
+0.7%		 GBX 3,700Sell    
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.

Always Get the Latest U.K. Analyst Ratings and Price Targets: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Tuesday at 09:26 AM ET.


See Also:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.